William Maclaughlin in Williamsburg, Virginia

Home Virginia Williamsburg

William Maclaughlin has Hematology/oncology as his primary medical specialty. Their primary office is: 120 Kings Way in Williamsburg, Virginia.

They're a part of the: Peninsula Cancer Institute, Llc medical group which has around 33 members. You can call their office at 757-345-5724 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended New York Medical College and graduated in 1981 (around 43 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

William W Maclaughlin Office Phone and Directions

William Maclaughlin
Peninsula Cancer Institute, Llc
120 Kings Way
Williamsburg, Virginia 23185
757-345-5724

Patient Ratings
Please rate your experience with William Maclaughlin below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 757-345-5724

Enter a starting address:

Healthcare Info for William Maclaughlin

Medical School: New York Medical College
Graduation Year: 1981
The Primary Medical Specialty for William Maclaughlin is listed as: Hematology/oncology
Approximate Years of Experience: 43
PAC (PECOS ID)#: 9739273335
NPI #: 1164487419
NPI Created On: 04/19/2006
NPI Last Updated Listed as: 01/27/2014
Primary Taxonomy Code: 207RH0003X
License Number:
0101034996
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Optima Health Plan
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787943639

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012533

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $160

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Payment was made by a third party for participation in a market research study on behalf of GSK.

Record ID:: 803000121

Being Disputed:: No

Product Related: No

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832137681

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832137683

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783715761

Being Disputed:: No

Product Related: Yes

Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783592765

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $20

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783592767

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783592795

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835991515

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: GAZYVA

Open Associated Drug #1: 50242-070-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: POLIVY

Associated Drug #2: 50242-105-01

Hematology/oncology Professionals in Williamsburg

1.
Flavia Kostov

120 Kings Way
Williamsburg, VA
Peninsula Cancer Institute, Llc

2.
Craig Franzman

120 Kings Way
Williamsburg, VA
Peninsula Cancer Institute, Llc

3.
Bo Zhao

500 Sentera Circle
Williamsburg, VA
Virginia Oncology Associates

4.
Amy Skorupa MD

120 Kings Way
Williamsburg, VA
Peninsula Cancer Institute, Llc

5.
Mashour Yousef MD

120 Kings Way
Williamsburg, VA
Peninsula Cancer Institute, Llc

6.
John Miller

120 Kings Way
Williamsburg, VA
Peninsula Cancer Institute, Llc

Providers in Peninsula Cancer Institute, Llc

1.Michail Alevizakos

110 Wimbledon Square
Chesapeake Va 23320-4946
Peninsula Cancer Institute, Llc
Hematology/oncology

2.Michail Alevizakos

1200 1st Colonial Rd
Virginia Beach Va 23454-2270
Peninsula Cancer Institute, Llc
Hematology/oncology

3.Kelly Armbruster

120 Kings Way
Williamsburg Va 23185-2506
Peninsula Cancer Institute, Llc
Nurse Practitioner

4.Kelly Armbruster

12100 Warwick Blvd
Newport News Va 23601-2365
Peninsula Cancer Institute, Llc
Nurse Practitioner

5.Ashrei Bayewitz

7544 Medical Dr
Gloucester Va 23061-4299
Peninsula Cancer Institute, Llc
Hematology/oncology

6.Ashrei Bayewitz

12100 Warwick Blvd
Newport News Va 23601-2365
Peninsula Cancer Institute, Llc
Hematology/oncology

View all 33 members of Peninsula Cancer Institute, Llc medical group